US20170049791A1 - Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome - Google Patents

Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome Download PDF

Info

Publication number
US20170049791A1
US20170049791A1 US15/347,696 US201615347696A US2017049791A1 US 20170049791 A1 US20170049791 A1 US 20170049791A1 US 201615347696 A US201615347696 A US 201615347696A US 2017049791 A1 US2017049791 A1 US 2017049791A1
Authority
US
United States
Prior art keywords
mg
zoledronic acid
kg
acid
form
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US15/347,696
Inventor
Herriot Tabuteau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Antecip Bioventures II LLC
Original Assignee
Antecip Bioventures II LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US201261646538P priority Critical
Priority to US201261647478P priority
Priority to US201261654383P priority
Priority to US201261654292P priority
Priority to US201261655541P priority
Priority to US201261655527P priority
Priority to US201361762225P priority
Priority to US201361764563P priority
Priority to US201361767676P priority
Priority to US201361767647P priority
Priority to US201361803721P priority
Priority to US13/894,274 priority patent/US20130303488A1/en
Priority to US14/063,979 priority patent/US8802658B2/en
Priority to US14/279,232 priority patent/US9149487B2/en
Priority to US14/635,857 priority patent/US9283239B2/en
Priority to PCT/US2015/032739 priority patent/WO2015184003A1/en
Priority to US15/055,386 priority patent/US20160175333A1/en
Priority to US15/347,696 priority patent/US20170049791A1/en
Application filed by Antecip Bioventures II LLC filed Critical Antecip Bioventures II LLC
Priority claimed from US15/364,117 external-priority patent/US20170071960A1/en
Priority claimed from US15/377,907 external-priority patent/US20170087168A1/en
Priority claimed from US15/408,783 external-priority patent/US20170119801A1/en
Priority claimed from US15/414,402 external-priority patent/US20170128472A1/en
Priority claimed from US15/416,995 external-priority patent/US9901589B2/en
Priority claimed from US15/421,205 external-priority patent/US20170136020A1/en
Publication of US20170049791A1 publication Critical patent/US20170049791A1/en
Assigned to ANTECIP BIOVENTURES II LLC reassignment ANTECIP BIOVENTURES II LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: TABUTEAU, Herriot
Priority claimed from US15/801,028 external-priority patent/US20180050053A1/en
Application status is Abandoned legal-status Critical

Links